Table 1.

Inclusion Criteria

1	Males or females ≥18 years of age
2	Patients with dry eye disease due to mild to moderate MGD as determined by:
	• TFBUT ≤10 s
	• OSDI© ≥16 and ≤55
	• Schirmer I Test ≥2 mm
	• Sum of peripheral corneal and conjunctival staining ≤grade 10 (Oxford grading scale, both eyes combined)
	• Altered secretion and expressibility of the Meibomian glands
3	Ability and willingness to apply eyelid hygiene for at least 14 days before enrollment
4	Patients must be under stable therapy (both topically and systemically) for at least 4 weeks before enrollment
5	Ability and willingness to provide written informed consent before enrollment
6	Ability and willingness to participate in all examinations
7	Ability and willingness to understand and fill in the OSDI questionnaire
8	Willingness and ability to return for the follow-up assessment at week 7 (weeks 6–8)

MGD, Meibomian gland dysfunction; OSDI, Ocular Surface Disease Index; TFBUT, tear film breakup time.